Postnatal Corticosteroids for Bronchopulmonary Dysplasia

Walsh, 2006, Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks, Pediatrics, 118, e1328, 10.1542/peds.2006-0359 American Academy of Pediatrics - American Academy of Pediatrics Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee, 2002, Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants, Pediatrics, 109, 330, 10.1542/peds.109.2.330 Finer, 2006, Prospective evaluation of postnatal steroid administration: a 1-year experience from the California Perinatal Quality Care Collaborative, Pediatrics, 117, 704, 10.1542/peds.2005-0796 Stark, 2001, Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network, N Engl J Med, 344, 95, 10.1056/NEJM200101113440203 Watterberg, 2004, Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial, Pediatrics, 114, 1649, 10.1542/peds.2004-1159 Halliday, 2003, Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev Halliday, 2003, Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants, Cochrane Database Syst Rev Halliday, 2003, Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev Doyle, 2006, Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial, Pediatrics, 117, 75, 10.1542/peds.2004-2843 Bhandari, 2008, Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia, Pediatrics, 121, e344, 10.1542/peds.2006-3668 Watterberg, 1996, Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops, Pediatrics, 97, 210, 10.1542/peds.97.2.210 Andrews, 2006, The Alabama Preterm Birth Study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants, Am J Obstet Gynecol, 195, 803, 10.1016/j.ajog.2006.06.083 Coalson, 2003, Pathology of new bronchopulmonary dysplasia, Semin Neonatol, 8, 73, 10.1016/S1084-2756(02)00193-8 De Dooy, 2003, Relationship between histologic chorioamnionitis and early inflammatory variables in blood, tracheal aspirates, and endotracheal colonization in preterm infants, Pediatr Res, 54, 113, 10.1203/01.PDR.0000069702.25801.D1 Speer, 2003, Inflammation and bronchopulmonary dysplasia, Semin Neonatol, 8, 29, 10.1016/S1084-2756(02)00190-2 Schmidt, 2006, Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP), J Pediatr, 148, 730, 10.1016/j.jpeds.2006.01.047 Watterberg, 2004, Adrenocortical function and dysfunction in the fetus and neonate, Semin Neonatol, 9, 13, 10.1016/j.siny.2003.08.003 Durand, 2002, A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation, Pediatrics, 109, 262, 10.1542/peds.109.2.262 Buttgereit, 1999, Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy, Biochem Pharmacol, 58, 363, 10.1016/S0006-2952(99)00090-8 Lee, 2008, Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone, Pediatrics, 121, 289, 10.1542/peds.2007-1103 Karemaker, 2006, Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone, Pediatr Res, 60, 745, 10.1203/01.pdr.0000246200.76860.de Shah, 2003, Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev Cole, 1999, Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia, N Engl J Med, 340, 1005, 10.1056/NEJM199904013401304 Dubus, 2007, Lung deposition of HFA beclomethasone dipropionate in an animal model of bronchopulmonary dysplasia, Pediatr Res, 61, 21, 10.1203/01.pdr.0000250055.26148.42 Watterberg, 1997, Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants, Pediatrics, 99, E6, 10.1542/peds.99.2.e6 Jobe, 2000, Fetal responses to glucocorticoids, 45 Kamphuis, 2007, Reduced life expectancy in rats after neonatal dexamethasone treatment, Pediatr Res, 61, 72, 10.1203/01.pdr.0000249980.95264.dd Liu, 2007, Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats, Pediatr Res, 61, 165, 10.1203/pdr.0b013e31802d89ff Wintour, 2003, Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment, J Physiol, 549, 929, 10.1113/jphysiol.2003.042408 Ikegami, 1997, Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs, Am J Respir Crit Care Med, 156, 178, 10.1164/ajrccm.156.1.9612036 Marlow, 2007, Motor and executive function at 6 years of age after extremely preterm birth, Pediatrics, 120, 793, 10.1542/peds.2007-0440 Short, 2003, Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes, Pediatrics, 112, e359, 10.1542/peds.112.5.e359 Ehrenkranz, 2005, Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia, Pediatrics, 116, 1353, 10.1542/peds.2005-0249 Inder, 2005, Abnormal cerebral structure is present at term in premature infants, Pediatrics, 115, 286, 10.1542/peds.2004-0326 Constable, 2008, Prematurely born children demonstrate white matter microstructural differences at 12 years of age, relative to term control subjects: an investigation of group and gender effects, Pediatrics, 121, 306, 10.1542/peds.2007-0414 Barrington, 2001, The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs, BMC Pediatr, 1, 1, 10.1186/1471-2431-1-1 Yeh, 2004, Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity, N Engl J Med, 350, 1304, 10.1056/NEJMoa032089 Murphy, 2001, Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease, Pediatrics, 107, 217, 10.1542/peds.107.2.217 LeFlore, 2002, Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates, Pediatrics, 110, 275, 10.1542/peds.110.2.275 Parikh, 2007, Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants, Pediatrics, 119, 265, 10.1542/peds.2006-1354 O'Shea, 1999, Randomized placebo-controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1 year adjusted age, Pediatrics, 104, 15, 10.1542/peds.104.1.15 O'Shea, 2007, Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age, Pediatrics, 120, 594, 10.1542/peds.2007-0486 Nixon, 2007, Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years, J Pediatr, 150, 345, 10.1016/j.jpeds.2006.12.013 Washburn, 2006, Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age, Pediatrics, 118, 1592, 10.1542/peds.2006-0973 Gross, 2005, Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease, Pediatrics, 115, 681, 10.1542/peds.2004-0956 Wilson, 2006, Pediatrics, 117, 2196, 10.1542/peds.2005-2194 Doyle, 2007, Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone, Pediatrics, 119, 716, 10.1542/peds.2006-2806 Watterberg, 2007, Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants, Pediatrics, 120, 40, 10.1542/peds.2006-3158 Rademaker, 2007, Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children, J Pediatr, 150, 351, 10.1016/j.jpeds.2006.10.051 Lodygensky, 2005, Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease, Pediatrics, 116, 1, 10.1542/peds.2004-1275 Karemaker, 2008, Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age, Pediatrics, 121, e870, 10.1542/peds.2007-2454 Shinwell, 2007, Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants, Arch Dis Child Fetal Neonatal Ed, 92, F30, 10.1136/adc.2006.094474 Doyle, 2005, Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease, Pediatrics, 115, 655, 10.1542/peds.2004-1238